Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Welltower Inc. (NYSE:WELL) is a real estate investment trust that owns and operates a large portfolio of residential wellness and healthcare properties in the U.S., the U.K., and Canada.
It is set to report its Q3 2025 earnings on Oct. 27. Wall Street analysts expect the company to post EPS of $0.82, down from $1.11 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $2.64 billion, up from $2.06 billion a year earlier.
Don't Miss:
* 40% of Americans Want a Vacation Home -- This Startup Found a Way to Make It Possible (and Profitable)
* They Sold Their Last Real Estate Company for Nearly $1B -- Now They're Building the Future of U.S. Industrial Growth
If You Bought Welltower Stock 10 Years Ago
The company's stock traded at approximately $62.39 per share 10 years ago. If you had invested $10,000, you could have bought roughly 160 shares. Currently, shares trade at $168.28, meaning your investment's value could have grown to $26,972 from stock price appreciation alone. However, Welltower also paid dividends during these 10 years.
Welltower's dividend yield is currently 1.77%. Over the last 10 years, it has paid about $31.84 in dividends per share, which means you could have made $5,103 from dividends alone.
Summing up $26,972 and $5,103, we end up with the final value of your investment, which is $32,075. This is how much you could have made if you had invested $10,000 in Welltower stock 10 years ago. This means a total return of 220.75%. However, this figure is less than the S&P 500 total return for the same period, which was 303%.
Trending: Bill Gates Invests Billions in Green Tech -- This Tree-Free Material Could Be the Next Big Breakthrough
What Could The Next 10 Years Bring?
Welltower has a consensus rating of "Overweight" and a price target of $123.08 based on the ratings of 25 analysts. The price target implies more than 26% potential downside from the current stock price.
The company on July 28 announced its Q2 2025 earnings, posting FFO of $1.28, compared to the consensus estimate of $1.23, and revenues of $2.55 billion, compared to the consensus of $2.43 billion, as reported by Benzinga.
For its full-year 2025, the company expects net income attributable to common stockholders of $1.86 to $1.94 per diluted share, up from the previous range of $1.70 to $1.84. It also increased the guidance range of full-year normalized FFO to a range of $5.06 to $5.14 per diluted share from the previous range of $4.90 to $5.04.